Sodium influx through cerebral sodium‐glucose transporter type 1 exacerbates the development of cerebral ischemic neuronal damage

No abstract is available for this paper.

• Publication year

  2017

• Venue

  European Journal of Pharmacology

• Publication date

  2017-03-15

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.ejphar.2017.02.007PMID 28174043
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sodium transport through the cerebral sodium–glucose transporter exacerbates neuron damage during cerebral ischaemia

  2016cited by this paper
• Evolution of acute ischemic stroke therapy from lysis to thrombectomy: Similar or different to acute myocardial infarction?

  2016cited by this paper
• Peripheral biomarkers of stroke: Focus on circulatory microRNAs.

  2016cited by this paper
• Hydroxysafflor Yellow A Protects Neurons From Excitotoxic Death through Inhibition of NMDARs

  2016cited by this paper
• Ionic homeostasis in brain conditioning

  2015cited by this paper
• A validation study of the use of near-infrared spectroscopy imaging in primary and secondary motor areas of the human brain.

  2015cited by this paper
• Relationship between cerebral sodium-glucose transporter and hyperglycemia in cerebral ischemia.

  2015cited by this paper
• Dynamics of Ionic Shifts in Cortical Spreading Depression

  2015cited by this paper
• Activation of cerebral sodium-glucose transporter type 1 function mediated by post-ischemic hyperglycemia exacerbates the development of cerebral ischemia.

  2015cited by this paper
• Prolonged Deficits in Parvalbumin Neuron Stimulation-Evoked Network Activity Despite Recovery of Dendritic Structure and Excitability in the Somatosensory Cortex following Global Ischemia in Mice

  2014cited by this paper
• The interactive roles of zinc and calcium in mitochondrial dysfunction and neurodegeneration

  2014cited by this paper
• Extrasynaptic glutamate release through cystine/glutamate antiporter contributes to ischemic damage.

  2014cited by this paper
• Unexpected effects of peripherally administered kynurenic acid on cortical spreading depression and related blood–brain barrier permeability

  2013cited by this paper
• Orexin-A Suppresses Postischemic Glucose Intolerance and Neuronal Damage through Hypothalamic Brain-Derived Neurotrophic Factor

  2013cited by this paper
• Neuroprotective effect through the cerebral sodium-glucose transporter on the development of ischemic damage in global ischemia.

  2013cited by this paper
• PDGF Suppresses Oxidative Stress Induced Ca2+ Overload and Calpain Activation in Neurons

  2013cited by this paper
• Post-ischemic hyperglycemia exacerbates the development of cerebral ischemic neuronal damage through the cerebral sodium-glucose transporter.

  2012cited by this paper
• RETRACTED: Ameliorating Effect of Hypothalamic Brain-Derived Neurotrophic Factor Against Impaired Glucose Metabolism After Cerebral Ischemic Stress in Mice.

  2012cited by this paper
• Ameliorating effect of hypothalamic brain-derived neurotrophic factor against impaired glucose metabolism after cerebral ischemic stress in mice.

  2012cited by this paper
• The involvement of cleavage of neural cell adhesion molecule in neuronal death under oxidative stress conditions in cultured cortical neurons.

  2012cited by this paper
• Metabolic and Perfusion Responses to Recurrent Peri-Infarct Depolarization during Focal Ischemia in the Spontaneously Hypertensive Rat: Dominant Contribution of Sporadic CBF Decrements to Infarct Expansion

  2011cited by this paper
• Biology of human sodium glucose transporters.

  2011cited by this paper
• RETRACTED: Effect of Orexin-A on Post-ischemic Glucose Intolerance and Neuronal Damage.

  2011cited by this paper
• Effect of orexin-A on post-ischemic glucose intolerance and neuronal damage.

  2011cited by this paper
• The role of spreading depression, spreading depolarization and spreading ischemia in neurological disease

  2011cited by this paper
• Involvement of Matrix Metalloproteinase-Mediated Proteolysis of Neural Cell Adhesion Molecule in the Development of Cerebral Ischemic Neuronal Damage

  2011cited by this paper
• Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies

  2010cited by this paper
• Impact of Glucose Tolerance Status on Development of Ischemic Stroke and Coronary Heart Disease in a General Japanese Population: The Hisayama Study

  2010cited by this paper
• The importance of regulation of blood glucose levels through activation of peripheral 5'-AMP-activated protein kinase on ischemic neuronal damage.

  2010cited by this paper
• The Na(+)/glucose cotransporters: from genes to therapy.

  2010cited by this paper
• The development of glucose intolerance after focal cerebral ischemia participates in subsequent neuronal damage.

  2009cited by this paper
• Mitochondrial calcium function and dysfunction in the central nervous system.

  2009cited by this paper
• Dissociation between sensing and metabolism of glucose in sugar sensing neurones

  2009cited by this paper
• Two-Photon Imaging of Stroke Onset In Vivo Reveals That NMDA-Receptor Independent Ischemic Depolarization Is the Major Cause of Rapid Reversible Damage to Dendrites and Spines

  2008cited by this paper
• Decreased mortality by normalizing blood glucose after acute ischemic stroke.

  2006cited by this paper
• Peri-infarct depolarizations lead to loss of perfusion in ischaemic gyrencephalic cerebral cortex.

  2006cited by this paper
• Sodium-Coupled Glucose Cotransporters Contribute to Hypothalamic Glucose Sensing

  2006cited by this paper
• Cerebral ischemia-induced apoptosis and necrosis in normal and diabetic rats: effects of insulin and C-peptide.

  2006cited by this paper
• Disorders of glucose metabolism in acute stroke patients: an underrecognized problem.

  2006cited by this paper
• The sodium/glucose cotransport family SLC5

  2004cited by this paper
• The glucose transporter families SGLT and GLUT: molecular basis of normal and aberrant function.

  2004cited by this paper
• Calcium: Regulation of cell death: the calcium–apoptosis link

  2003cited by this paper
• The sodium/glucose cotransport family SLC5

  2003cited by this paper
• A novel glucose-sensing mechanism contributing to glucagon-like peptide-1 secretion from the GLUTag cell line.

  2003cited by this paper
• Mechanisms of spreading depression and hypoxic spreading depression-like depolarization.

  2001cited by this paper
• Stress Hyperglycemia and Prognosis of Stroke in Nondiabetic and Diabetic Patients: A Systematic Overview

  2001cited by this paper
• Na+‐Dependent and Phlorizin‐Inhibitable Transport of Glucose and Cycasin in Brain Endothelial Cells

  1998cited by this paper
• Expression of the Na+‐d‐Glucose Cotransporter SGLT1 in Neurons

  1997cited by this paper
• Prognosis after stroke in diabetic patients. A controlled prospective study

  1990cited by this paper
• Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse.

  1957cited by this paper

• Pharmacological mechanisms and clinical applications between SGLT1 and SGLT2 inhibitors in type 2 diabetes and diabetic kidney disease: An analytic review.

  2025cites this paper
• Protective effects of empagliflozin against NMDA-induced excitotoxicity in the rat retina.

  2025cites this paper
• SGLT1 inhibition alleviates radiation-induced intestinal damage through promoting mitochondrial homeostasis.

  2024cites this paper
• Canagliflozin ameliorates neuronal injury after cerebral ischemia reperfusion by targeting SGLT1 and AMPK-dependent apoptosis

  2023cites this paper
• Comparison of SGLT1, SGLT2, and Dual Inhibitor Biological Activity in Treating Type 2 Diabetes Mellitus

  2023cites this paper
• Canagliflozin, an Inhibitor of the Na+-Coupled D-Glucose Cotransporter, SGLT2, Inhibits Astrocyte Swelling and Brain Swelling in Cerebral Ischemia

  2023cites this paper
• GLP-1 Analogs, SGLT-2, and DPP-4 Inhibitors: A Triad of Hope for Alzheimer’s Disease Therapy

  2023cites this paper
• Ginsenoside Rd protects cerebral endothelial cells from oxygen-glucose deprivation/reoxygenation induced pyroptosis via inhibiting SLC5A1 mediated sodium influx

  2022cites this paper
• Noninvasive Delivery of Biologicals to the Brain.

  2022cites this paper
• Neuroprotective Effect of SGLT2 Inhibitors

  2021cites this paper
• Mizagliflozin, a selective SGLT1 inhibitor, improves vascular cognitive impairment in a mouse model of small vessel disease

  2021cites this paper
• SGLT1 participates in the development of vascular cognitive impairment in a mouse model of small vessel disease.

  2020cites this paper
• SGLT2 inhibitors and cardioprotection: a matter of debate and multiple hypotheses

  2019cites this paper
• Retraction and republication—Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment

  2018cites this paper
• RS1 (Rsc1A1) deficiency limits cerebral SGLT1 expression and delays brain damage after experimental traumatic brain injury

  2018cites this paper
• Emerging Concepts in Brain Glucose Metabolic Functions: From Glucose Sensing to How the Sweet Taste of Glucose Regulates Its Own Metabolism in Astrocytes and Neurons

  2018cites this paper
• Sodium–glucose transporter as a novel therapeutic target in disease

  2018cites this paper
• SGLT1 inhibition: Pros and cons

  2018cites this paper
• SGLT2 inhibitors: hypotheses on the mechanism of cardiovascular protection.

  2017cites this paper